Optibiotix Health Plc Q&A CEO Stephen OHara: Mitigating risk / Exploiting opportunities
Optibiotix Health Plc (LON:OPTI) this morning announced a new development agreement with Centro Sperimentale del Latte to synthesise and purify novel oligosaccharides from microbial strains. DirectorsTalk caught up with Stephen